Teragawa Hiroki, Oshita Chikage, Orita Yuichi
Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan.
Clin Med Insights Cardiol. 2020 Jun 15;14:1179546820918903. doi: 10.1177/1179546820918903. eCollection 2020.
Many causes of noncardiac chest pain (NCCP) have been studied and gastroesophageal reflux disease is considered to be the major cause. However, studies have reported that treatment with a proton pump inhibitor does not effectively provide relief for NCCP-related symptoms, and these symptoms frequently recur. These findings suggest that patients with cardiac disease may be excluded completely from the NCCP group. Several examinations can be conducted to verify the presence of cardiac disease. Such examinations include the assessment of biochemical markers, rest and exercise electrocardiogram, echocardiography, cardiac computed tomography, stress myocardial perfusion imaging, cardiac magnetic resonance imaging, and coronary angiography (CAG). However, the presence of functional coronary artery diseases (CADs), such as vasospastic angina and/or microvascular angina, cannot be detected using these modalities. These functional CADs can be diagnosed by CAG with spasm-provocation testing and/or physiological coronary measurement. Thus, when a patient who is suspected of having NCCP takes a proton pump inhibitor and does not respond well, further examination-including assessment for possible functional CADs-may be needed.
许多非心源性胸痛(NCCP)的病因已得到研究,胃食管反流病被认为是主要病因。然而,研究报告称,使用质子泵抑制剂治疗并不能有效缓解与NCCP相关的症状,且这些症状经常复发。这些发现表明,患有心脏病的患者可能会被完全排除在NCCP组之外。可以进行多项检查以核实是否存在心脏病。此类检查包括生化标志物评估、静息和运动心电图、超声心动图、心脏计算机断层扫描、负荷心肌灌注成像、心脏磁共振成像以及冠状动脉造影(CAG)。然而,使用这些方法无法检测到功能性冠状动脉疾病(CAD),如血管痉挛性心绞痛和/或微血管性心绞痛。这些功能性CAD可通过CAG加痉挛激发试验和/或生理性冠状动脉测量来诊断。因此,当疑似患有NCCP的患者服用质子泵抑制剂且反应不佳时,可能需要进一步检查,包括评估是否可能存在功能性CAD。